Clinical Trial Update: A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial update of an Encapsulated Cell Technology implant for atrophic (dry) age-related macular degeneration; the study has completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dry Age-related Macular Degeneration

Drugs mentioned

• Encapsulated Cell Technology (ECT) Implant

Snippet

Sponsor: Neurotech Pharmaceuticals | Conditions: Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage | Phase 2 | Status: COMPLETED | Results posted: 2025-03-28